三种产前物质使用筛查工具的准确性
这项前瞻性横断面研究在巴尔的摩两个产前临床机构连续纳入500名孕妇,比较4P's Plus、NIDA Quick Screen-ASSIST和SURP-P筛查非法药物使用及处方药误用的准确性。SURP-P和4P's Plus敏感性高、阴性预测值高,比NIDA Quick Screen-ASSIST更理想。
要点
- SURP-P敏感性92.4%、4P's Plus敏感性90.2%,均高于NIDA Quick Screen-ASSIST的79.7%。
- NIDA Quick Screen-ASSIST特异性82.8%,高于4P's Plus的29.6%和SURP-P的21.8%。
- 三种工具重测信度(phi相关系数)分别为0.84、0.77、0.79。
核心结论
- SURP-P和4P's Plus具有高敏感性和高阴性预测值,作为筛查工具比NIDA Quick Screen-ASSIST更理想。
- 作者认为,明确推荐一种临床有用的产前物质使用筛查工具对于及时适当的随访和干预至关重要。
研究设计与样本
- 前瞻性横断面研究,连续纳入500名孕妇,按孕期分层,2017年1月至2018年1月在马里兰州巴尔的摩两个产前临床机构接受照护。
- 所有参与者接受三种指数试验:4P's Plus、NIDA Quick Screen-ASSIST和SURP-P量表,并在面对面基线访视时接受参考试验(尿液和毛发药物检测)。
- 为评估重测信度,1周后通过电话重复进行筛查工具施测。
- 计算每种筛查工具的敏感性、特异性、阳性预测值、阴性预测值和重测信度,结果按年龄、种族和孕期分层。
主要发现
- 500名入组孕妇中,494名完成指数筛查工具,497名完成参考检测,453名接受重测分析。
- 4P's Plus敏感性90.2%(95%CI 84.5–93.8),特异性29.6%(95%CI 24.4–35.2)。
- NIDA Quick Screen-ASSIST敏感性79.7%(95%CI 71.2–84.2),特异性82.8%(95%CI 78.1–87.1)。
- SURP-P敏感性92.4%(95%CI 87.6–95.8),特异性21.8%(95%CI 17.4–27.2)。
- 重测信度(phi相关系数):4P's Plus为0.84,NIDA Quick Screen-ASSIST为0.77,SURP-P为0.79。
临床怎么用
- SURP-P和4P's Plus因高敏感性和高阴性预测值,作为筛查工具比NIDA Quick Screen-ASSIST更理想。
- 作者认为,明确推荐一种临床有用的产前物质使用筛查工具对于及时适当的随访和干预至关重要。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare and evaluate the accuracy of three screening tools in identifying illicit drug use and prescription drug misuse among a diverse sample of pregnant women. METHODS: This prospective cross-sectional study enrolled a consecutive sample of 500 pregnant women, stratified by trimester, receiving care in two prenatal clinical settings in Baltimore, Maryland, from January 2017 to January 2018. All participants were administered three index tests: 4P's Plus, NIDA Quick Screen-ASSIST (Modified Alcohol, Smoking and Substance Involvement Screening Test), and the SURP-P (Substance Use Risk Profile-Pregnancy) scale, and administered reference tests (urine and hair drug testing) at the in-person baseline visit. To assess test-retest reliability of the index tests, screening tool administrations were repeated 1 week later by telephone. For each screening tool, sensitivity, specificity, positive predictive value, negative predictive value and test-retest reliability were computed. Results were stratified by age, race, and trimester of pregnancy. RESULTS: Of the 500 enrolled pregnant women, 494 completed the index screening tools, 497 completed reference testing, and 453 underwent test-retest analysis. For the 4P's Plus, sensitivity=90.2% (84.5, 93.8), and specificity=29.6% (24.4, 35.2). For the NIDA Quick Screen-ASSIST, sensitivity=79.7% (71.2, 84.2), and specificity=82.8% (78.1, 87.1). For the SURP-P, sensitivity=92.4% (87.6, 95.8) and specificity=21.8% (17.4, 27.2). Test-retest reliability (phi correlation coefficients) was 0.84, 0.77, and 0.79 for the 4P's Plus, NIDA Quick Screen-ASSIST and the SURP-P, respectively. For all screening tools, there were differences in validity indices by age and race, but no differences by trimester. CONCLUSION: The SURP-P and 4P's Plus had high sensitivity and negative predictive values, making them more ideal screening tests than the NIDA Quick Screen-ASSIST. A clear recommendation for a clinically useful screening tool for prenatal substance use is crucial to allow for prompt and appropriate follow-up and intervention.
引用
- Coleman-Cowger VH, Oga EA, Peters EN, et al. Accuracy of Three Screening Tools for Prenatal Substance Use. Obstet Gynecol. 2019. PMID: 30969217. doi:10.1097/AOG.0000000000003230
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。